<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is the most common <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in humans </plain></SENT>
<SENT sid="1" pm="."><plain>The treatment can be one of the most difficult </plain></SENT>
<SENT sid="2" pm="."><plain>It's true that AF itself it's a no-lethal <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> but is often a cause of symptoms that can lead the patient to worsening in his quality of life thet predispose to serious conditions like <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>There is a general agreement in the benefit of antithrombotic therapy and the need of control of comorbid conditions, but there is not an ideal treatment for AF and the choice for the best treatment is based on the individual differences of each patient </plain></SENT>
<SENT sid="4" pm="."><plain>Physician and patient must be aware of the risks and possible complications as well as the options in antiarrhythmic and antithrombotic drugs available in order to choose the best for each patient </plain></SENT>
<SENT sid="5" pm="."><plain>We must get the message across that AF patients show a dynamic curse of the disease so reevaluation of the individual risk and response to therapy should be made </plain></SENT>
</text></document>